Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation: Kemira to publish January-March 2024 results on April 26, 2024

Kemira Oyj, Press Release, April 12, 2024 at 9.00 am (EEST)Invitation: Kemira to publish January-March 2024 results on April 26, 2024   Kemira Oyj will publish its January-March 2024 results on Friday, April 26, 2024, at around 8.30 am Finnish time (6.30 am UK time).  Webcast for analysts, investors, and media will be held on Friday, April 26, 2024, starting at 10.30 am (8.30 am UK time). At the webcast, Kemira’s President and CEO Antti Salminen and CFO Petri Castrén will present the results. The webcast will be held in English and can be followed at kemira.com/investors 

Norse Atlantic ASA – Annual report for 2023

Arendal, 12[th] April 2024: The board of directors of Norse Atlantic ASA ("Norse" or the "Company") has approved Norse's Annual Report for 2023. Please find attached the Annual Report 2023 for Norse (ESEF and pdf), including reporting on corporate governance and complete annual accounts with notes. The report will also be available on the Company’s website www.flynorse.com. Contacts: Investors: CFO, Anders Hall Jomaas, anders.jomaas@flynorse.com Media: SVP Communications, Philip Allport, philip.allport@flynorse.com About Norse Atlantic ASA: Norse Atlantic Airways is an

Moberg Pharma Annual report for 2023

Moberg Pharma´s Annual report for 2023 has been published and is available on www.mobergpharma.seFor additional information, please contact:Anna Ljung, VD, phone: +46 707 66 6030, e-mail: anna.ljung@mobergpharma.seMark Beveridge, CFO, phone: +46 76 805 82 88, e-mail: mark.beveridge@mobergpharma.se (www.mobergpharma.se) About this informationThis information is information that Moberg Pharma AB (publ.) is obliged to make public in accordance with the Securities Market Act. The information was submitted for publication, through the contact persons set out above at 08.00 p.m CET on

WindowMaster narrows the 2024 guidance in the high end of the previous announced range:

Company Announcement No. 043-2024Vedbaek,12 April 2024Record high order intake for Q1 2024 · Order intake reached a record high level end of Q1 amounted to DKK 74m for Q1 2024 and DKK 268m 12-month-running (2023: DKK 60m for Q1 and DKK 244m 12-month-running). This represents a growth of 24% for the quarter and 10% 12-month-running. The strong growth is coming from all our main markets (except Nordic) and is seen as being able to deliver on the strategy “Accelerate-Core” as it is mainly the project business driving the growth. We also see some improvements from our Key Accounts –

BlueNord: Notice of Annual General Meeting 2024

Oslo, 12 April 2024: The annual general meeting of BlueNord ASA ("BlueNord" or the "Company") will be held 14 May 2024 at 12:00 CEST. The general meeting will be held as a digital meeting only, with no physical attendance for shareholders. Information about log-in details for the meeting and documents to be processed in the meeting are available in the attached Calling Notice and/or will be available on the Company's website www.bluenord.com.  This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.  ***

Interim Report January – March 2024

– We are at the bottom of the recession, but despite the gloomy economy, there is still business to be done, and rent levels are stable. Delivering an increased in profit from property management of 14% in these times is strong, says Annica Ånäs, CEO of Atrium Ljungberg.· Rental income amounted to SEK 755 million (SEK 712 m) – of which comparable portfolios increased by 4.9% (11.7%).  · Net operating income amounted to SEK 541 million (SEK 489 m) – of which comparable portfolios increased by 8.1% (14.9%).   · Net sales for project and construction work amounted to SEK 111 million (

Skanska announces decreased scope for facility in Everett, Washington, USA, worth USD 49M, about SEK 510M

Skanska announces that Pfizer has reduced the scope of work on its 25,000 square-meter biomanufacturing facility in Everett, Washington, USA, which Skanska previously was contracted to construct. The order reduction amounts to USD 49M, about SEK 510M, which will be deducted from the US order bookings for the first quarter 2024.The initial contract with Seagen, who recently was acquired by Pfizer, was worth USD 215M, about SEK 2.2 billion, and was announced August 4, 2023.

NCC to refurbish 210 apartments in Herning

NCC has been commissioned by the municipal company FællesBo to refurbish 210 apartments in the Mindeparken residential area in Herning, Denmark. The project is a turnkey contract, and the order value is approximately SEK 350 million. NCC’s assignment includes the refurbishment and some remodeling of six residential blocks built in 1956. The project involves replacing all technical installations to improve the indoor climate and eliminate damp and cold problems, and renovating bathrooms, kitchens, surface finishes and floors. A third of the residential units will also be remodeled

Notice of Annual General Meeting of Ambea AB (publ)

Ambea AB (publ), Reg.No. 556468-4354, with its registered office in Stockholm, gives notice of the Annual General Meeting to be held on Wednesday 15 May 2024 at 10.00 a.m. at Nytidas dagliga verksamhet, Liljeholmen Öst, Katrinebergsvägen 6, SE-117 43 Stockholm, Sweden. Registration starts at 09.30 a.m.Right to participate in the Annual General Meeting and notice of participation Participation in the Annual General Meeting at the venue A shareholder who wishes to participate in the Annual General Meeting at the venue in person or represented by a proxy must i. be recorded in the

Multiconsult – Ex. dividend NOK 8.00 today

Multiconsult (Oslo: MULTI)The shares in Multiconsult ASA will be traded ex-dividend NOK 8.00 as of today, 12 April 2024.Contact:Investor relations:   Pål-Sverre Jørgensen, Group Treasurer & IRO   Phone: +47 416 11 161   E-mail: ir@multiconsult.no / psmj@multiconsult.noMedia:   Gaute Christensen, VP Communications   Phone: +47 911 70 188   E-mail: gaute.christensen@multiconsult.no www.multiconsult-ir.com This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

European energy company Alpiq acquires majority share of Enersense’s associated company P2X Solutions

Enersense International PlcInvestor news, 12 April 2024 at 8:00 a.m.Enersense’s associated company P2X Solutions (P2X), a Finnish forerunner of green hydrogen, and Alpiq, a leading Swiss energy services provider and European electricity producer, have agreed on a financing arrangement according to which Alpiq will invest approximately 47 million euros in P2X. With the investment, Alpiq becomes the majority owner of P2X. Respectively, in connection with the arrangement, Enersense’s shareholding will decrease to approximately 9 percent. Enersense continues at the Board of P2X and thus

Vår Energi: First quarter 2024 trading update

Sandnes, Norway, 12 April 2024: Vår Energi ASA (OSE: VAR, the "Company") will publish its financial report for the first quarter 2024 on Tuesday 23 April. Today, the Company provides an update on production, sales volumes, and other relevant items. Vår Energi’s net production of oil, liquids and natural gas averaged 299 kboepd in the first quarter of 2024, an increase of 33% from the fourth quarter of 2023 and an increase of 40% compared to the first quarter of 2023. The increased production in the quarter reflects volumes from Vår Energi Norge AS (formerly Neptune Energy Norge AS)

Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.

Company release, inside information 12 April 2024 at 7.15 a.m. (EEST)   Nightingale Health has entered into an agreement with Kaiser Foundation Health Plan, Inc. to analyze 50,000 blood samples from the Kaiser Permanente Research Bank. As part of the agreement, Nightingale Health will analyze the 50,000 blood samples with its proprietary technology and deliver the blood biomarker data to the Kaiser Permanente Research Bank.   Kaiser Foundation Health Plan, Inc. together with Kaiser Foundation Hospitals and its subsidiaries and the Permanente Medical Groups, form one of the

White Pearl Technology Group AB controls 87,48 percent of the shares in Ayima Group AB (publ) after the completion of the public offer

White Pearl Technology Group AB (”White Pearl”) announced on 20[th] February 2024 a public offer to the shareholders of Ayima Group AB (publ) (”Ayima Group”) to acquire all shares in Ayima Group (the “Offer”). On 27[th] March 2024, White Pearl announced the decision to extend the acceptance period in the Offer to 10[th] April 2024, in order to give the remaining shareholders of Ayima group the opportunity to accept the Offer. White Pearl has today decided not to extend the acceptance period in the Offer further. The Offer has been accepted to such an extent that after completion, White Pearl

Determination of Share Price and Number of Shares for Payment of Additional Purchase Price

In accordance with the outcome of the additional purchase price for the acquisition of the subsidiary W&IT Solutions, the number of shares has now been determined. The price per share has been calculated through a 30-day VWAP (Volume Weighted Average Price) between February 8 and March 20, 2024, and amounted to 0.73 SEK. The number of new shares amounted to 2,054,794. Number of shares after issuance 34,532,817Share capital after issuance 1,553,976.78 SEK

Notice to the Annual General Meeting of Duni AB (publ), May 21, 2024

In accordance with the listing agreement with Nasdaq Stockholm, Duni AB hereby also announces, by issuing a press release, the content of the notice concerning Duni’s Annual General Meeting on May 21, 2024. The shareholders of Duni AB (publ), Reg. No. 556536-7488, are hereby invited to attend the Annual General Meeting to be held on Tuesday, 21 May 2024, at 15.00 p.m. at Glasklart, Dockplatsen 1, in Malmö, Sweden. Registration starts at 14.15 p.m. The board of directors has decided that shareholders shall be able to exercise their voting rights at the annual general meeting also by

Toy Monsters Brings Tactical Tabletop Defense to Mixed Reality with Today’s Launch on Meta Quest

STOCKHOLM, APRIL 11, 2024  — Family-friendly fun defending against a march of monsters arrives in the real world today courtesy of Beyond Frames Entertainment ’s Toy Monsters  (TRAILER ), now available on the Meta Quest Store. Inspired by classics of the tower defense genre, Toy Monsters delivers a digital celebration of casual strategy that you can set up on any physical surface thanks to the power of passthrough play. Toy Monsters is also optimized for hand-tracking,

SBB announces date for Annual Report and updates its financial calendar

SBB announces the date for the publication of the Annual Report 2023 as well as the updated calendar with new dates for the publication of interim reports. New calendar: · Annual report 2023: w/c 29 April · Interim report January-March 2024: 6 May (previously 26 April) · Interim report January-June 2024: 28 August (previously 16 July) · Interim report January-September 2024: 28 November (previously 25 October) The updated financial calendar can be found on the company’s website. For further information, please contact:Helena Lindahl, Treasury Director, ir@sbbnorden.

Result of AGM

11 April 2024 1730 BST Results of Annual General Meeting held on 11 April 2024 AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 11 - 14 were passed as special resolutions; all other resolutions were passed as ordinary resolutions. Resolution Votes for % of Votes % of Votes cast in Total Votes votes against votes total votes withheld

Minutes of annual general meeting 2024

Multiconsult ASA (Oslo: MULTI) has held the 2024 annual general meeting. The meeting took place today, 11 April 2024.All items on the agenda were approved as proposed. Please find attached minutes from annual general meeting 2024 for Multiconsult ASA.Contact:Investor relations:   Pål-Sverre Jørgensen, Group Treasurer & IRO   Phone: +47 416 11 161   E-mail: ir@multiconsult.no / psmj@multiconsult.noMedia:   Gaute Christensen, VP Communications   Phone: +47 911 70 188   E-mail: gaute.christensen@multiconsult.no This information is subject of the disclosure requirements

Further re: Notice of Extraordinary General Meeting - Amendments to Resolution

[A green letter in a triangle shape Description automatically generated]          Thursday, 11 April 2024 KR1 plc (“KR1” or the “Company”)   Further re: Notice of Extraordinary General Meeting  - Amendments to Resolution   Further to the Company's announcement of 10 April 2024 regarding the convening of an Extraordinary General Meeting of the Company for 10.00 a.m. on 29 April 2024, the Company announces its intention to amend the Resolution to be proposed at the EGM to clarify the minimum and maximum price at which the Company may make market acquisitions

There are no items matching the current filter
There are no more items matching the current filter
Back to top